NCT00377546

Brief Summary

To compare the penetration of three different NSAIDs.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 18, 2006

Completed
Last Updated

September 25, 2008

Status Verified

September 1, 2008

First QC Date

September 14, 2006

Last Update Submit

September 23, 2008

Conditions

Vitrectomy

Keywords

Retinal Surgery

Interventions

NepafenacDRUG
Ketorolac LS, BromfenacDRUG

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Males or females scheduled to undergo Vitrectomy surgery
  • Likely to complete all study visits and able to provide informed consent
  • Visual potential of 20/25 or better

You may not qualify if:

  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease
  • Active ocular allergies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmic Consultants of Boston

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Interventions

nepafenacbromfenac

Study Officials

  • Jeffrey Heier, MD

    Ophthalmic Consultants of Boston

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 14, 2006

First Posted

September 18, 2006

Last Updated

September 25, 2008

Record last verified: 2008-09

Locations

US(1)